Variant report
Variant | nsv965694 |
---|---|
Chromosome Location | chr6:26857981-26860369 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOXA1 | chr6:26858126-26858442 | HepG2 | liver: | n/a | n/a |
2 | PBX3 | chr6:26858272-26858414 | GM12878 | blood: | n/a | n/a |
3 | POU2F2 | chr6:26858325-26858444 | GM12878 | blood: | n/a | n/a |
4 | SP1 | chr6:26858234-26858483 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
GUSBP2 | TF binding region |
ENSG00000243307 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75528464 | chr6:26858016-26858017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534727116 | chr6:26858017-26858018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs370099396 | chr6:26858031-26858032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs10214927 | chr6:26858032-26858033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs549685745 | chr6:26858063-26858064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs200086893 | chr6:26858103-26858104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10214924 | chr6:26858109-26858110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10214678 | chr6:26858112-26858113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs551357437 | chr6:26858113-26858114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs373809465 | chr6:26858125-26858126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571268331 | chr6:26858159-26858160 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs537739903 | chr6:26858187-26858188 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs557668435 | chr6:26858210-26858211 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs9295709 | chr6:26858220-26858221 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs370926630 | chr6:26858221-26858222 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs10214417 | chr6:26858261-26858262 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs533351798 | chr6:26858268-26858269 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs141658974 | chr6:26858270-26858271 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs139400474 | chr6:26858272-26858273 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs142853593 | chr6:26858318-26858319 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs200196409 | chr6:26858368-26858369 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs200831510 | chr6:26858378-26858379 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs201796918 | chr6:26858424-26858425 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs536825225 | chr6:26858425-26858426 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs200583614 | chr6:26858432-26858433 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs201659484 | chr6:26858440-26858441 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs572961216 | chr6:26858453-26858454 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs200139853 | chr6:26858463-26858464 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs70981114 | chr6:26858489-26858490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10214418 | chr6:26858513-26858514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs3925440 | chr6:26858527-26858528 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
32 | rs558523533 | chr6:26858528-26858529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs150883641 | chr6:26858543-26858544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs534070030 | chr6:26858586-26858587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs368178630 | chr6:26858588-26858589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372130933 | chr6:26858616-26858617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs543337571 | chr6:26858653-26858654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs563628778 | chr6:26858666-26858667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185844552 | chr6:26858667-26858668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs139372375 | chr6:26858678-26858679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs368093003 | chr6:26858721-26858722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs111642909 | chr6:26858730-26858731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572780099 | chr6:26858762-26858763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs376439589 | chr6:26858797-26858798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs12181157 | chr6:26858818-26858819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs551549073 | chr6:26858880-26858881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs189825017 | chr6:26858899-26858900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12177897 | chr6:26858906-26858907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs374707018 | chr6:26858927-26858928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs199620037 | chr6:26858936-26858937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 21569311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21509527 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:26838000-26866200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr6:26841400-26866200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr6:26844400-26865800 | Weak transcription | Ovary | ovary |
4 | chr6:26844400-26872000 | Weak transcription | Fetal Intestine Small | intestine |
5 | chr6:26845000-26864200 | Weak transcription | Pancreas | Pancrea |
6 | chr6:26849200-26866800 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
7 | chr6:26849400-26866600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr6:26849800-26864200 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
9 | chr6:26850400-26865000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
10 | chr6:26852000-26866200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr6:26853600-26864000 | Weak transcription | Fetal Stomach | stomach |